A new drug described as “the closest we have ever been to an HIV vaccine” could be sold for $40 a year and still make 30% profit, but is currently being sold by pharma companies for $42,250. Absolutely criminal.

https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing

Reply to this note

Please Login to reply.

Discussion

30% profit & $40 a year are, qoute: "based on the costs of lenacapavir’s ingredients and manufacturing". Not that I'm a fan of the pharma industry fleecing sick people. But I am under the impression that research is a pretty expensive part.